Skip to main content
OpenTrials
Recruiting

NCT Number: NCT03770936

Effect of Some Drugs on Liver Fibrosis

Effect of Some Drugs on Liver Fibrosis

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Liver Fibroses Digestive System Diseases Fibrosis Liver Cirrhosis Liver Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

20 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

Sherief Abd-Elsalam

Tanta, 35111, Egypt

Location status: Recruiting

Location contact

Abeer Abd-Almohsen, Msc

CONTACT

About this study

The study aimed at evaluating the effect of Some Drugs on Liver Fibrosis

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • chronic hepatitis C

Exclusion criteria

  • Acute hepatitis
  • Thalassemia

Treatment and study plan

Candesartan

Drug

Candesartan 8 mg/day

Other names: Cansartan

Ramipril

Drug

ramipril 1.25 mg/day

Primary outcomes

  1. Change in Fibroscan or APRI score

    Time frame: 6 months

    Change in Fibroscan or APRI score

Study contacts

Contact information is provided by the study sponsor or research team.

Sherief Abd-Elsalam, Ph D

CONTACT

[email protected]

00201147773440

Sponsors and collaborators

Lead sponsor

Sherief Abd-Elsalam

Other

Registry information

Official study title

Clinical Study Evaluating the Efficacy of Renin Angiotensin System Inhibitors on the Extent of Liver Fibrosis in Patients With Chronic Hepatitis C

Important dates

Study start
2018
Primary completion
2026
Study completion
2027
First posted
Dec 10, 2018
Registry last updated
Dec 10, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.